DE69535886D1 - Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen - Google Patents
Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungenInfo
- Publication number
- DE69535886D1 DE69535886D1 DE69535886T DE69535886T DE69535886D1 DE 69535886 D1 DE69535886 D1 DE 69535886D1 DE 69535886 T DE69535886 T DE 69535886T DE 69535886 T DE69535886 T DE 69535886T DE 69535886 D1 DE69535886 D1 DE 69535886D1
- Authority
- DE
- Germany
- Prior art keywords
- nucleic acids
- transformed cells
- galanine receptor
- receptor
- galanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9401808A FR2716205B1 (fr) | 1994-02-17 | 1994-02-17 | Récepteur galanine, acides nucléiques, cellules transformées et utilisations. |
PCT/FR1995/000172 WO1995022608A1 (fr) | 1994-02-17 | 1995-02-14 | Recepteur galanine, acides nucleiques, cellules transformees et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69535886D1 true DE69535886D1 (de) | 2009-01-02 |
Family
ID=9460177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69535886T Expired - Lifetime DE69535886D1 (de) | 1994-02-17 | 1995-02-14 | Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen |
Country Status (12)
Country | Link |
---|---|
US (2) | US6447996B1 (de) |
EP (1) | EP0745122B1 (de) |
JP (1) | JP3989536B2 (de) |
AT (1) | ATE414771T1 (de) |
AU (1) | AU1814995A (de) |
CA (1) | CA2182621C (de) |
DE (1) | DE69535886D1 (de) |
DK (1) | DK0745122T3 (de) |
ES (1) | ES2317643T3 (de) |
FR (1) | FR2716205B1 (de) |
PT (1) | PT745122E (de) |
WO (1) | WO1995022608A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0711830A3 (de) * | 1994-10-13 | 1997-06-11 | Takeda Chemical Industries Ltd | Menschlicher und muriner Galanin Rezeptor |
AU730137B2 (en) | 1996-01-24 | 2001-03-01 | H. Lundbeck A/S | DNA encoding galanin GALR2 receptors and uses thereof |
US5972624A (en) * | 1996-01-24 | 1999-10-26 | Synaptic Pharmaceutical Corporation | Method of identifying ligands which bind recombinant galanin receptor (GALR2) |
US6410686B1 (en) * | 1996-06-05 | 2002-06-25 | Bayer Corporation | Galanin receptor 2 protein |
SE9602822D0 (sv) | 1996-07-19 | 1996-07-19 | Astra Pharma Inc | New receptor |
US6329197B2 (en) * | 1996-10-09 | 2001-12-11 | Synaptic Pharmaceutical Corporation | DNA encoding galanin GALR3 receptors and uses thereof |
US6693182B1 (en) | 1997-08-22 | 2004-02-17 | Schering Corporation | Mammalian galanin receptors |
US20020137132A1 (en) * | 2000-04-06 | 2002-09-26 | Gabriel Vogeli | Novel G protein-coupled receptors |
CA2459183A1 (en) * | 2001-08-27 | 2003-03-06 | Tularik Inc. | Amplified oncogenes and their involvement in cancer |
JP2008517930A (ja) * | 2004-10-21 | 2008-05-29 | トランス テック ファーマ,インコーポレイテッド | GalR1のアゴニストとしてのビススルホンアミド化合物、組成物、及び使用法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015015A1 (en) * | 1991-02-25 | 1992-09-03 | Zymogenetic, Inc. | Methods for detecting galanin antagonists |
SE9101472D0 (sv) * | 1991-05-15 | 1991-05-15 | Trion Forskning & Utveckling | Galanin antagonist |
JP3719712B2 (ja) * | 1992-06-23 | 2005-11-24 | ザ マウント シナイ スクール オブ メディシン オブ ザ シティー ユニバーシティー オブ ニューヨーク | ゴナドトロピン放出ホルモン受容体のクローニングおよび発現 |
-
1994
- 1994-02-17 FR FR9401808A patent/FR2716205B1/fr not_active Expired - Lifetime
-
1995
- 1995-02-14 CA CA2182621A patent/CA2182621C/fr not_active Expired - Lifetime
- 1995-02-14 AT AT95909825T patent/ATE414771T1/de active
- 1995-02-14 EP EP95909825A patent/EP0745122B1/de not_active Expired - Lifetime
- 1995-02-14 PT PT95909825T patent/PT745122E/pt unknown
- 1995-02-14 WO PCT/FR1995/000172 patent/WO1995022608A1/fr active Application Filing
- 1995-02-14 JP JP52162795A patent/JP3989536B2/ja not_active Expired - Lifetime
- 1995-02-14 DK DK95909825T patent/DK0745122T3/da active
- 1995-02-14 ES ES95909825T patent/ES2317643T3/es not_active Expired - Lifetime
- 1995-02-14 AU AU18149/95A patent/AU1814995A/en not_active Abandoned
- 1995-02-14 DE DE69535886T patent/DE69535886D1/de not_active Expired - Lifetime
- 1995-02-14 US US08/693,308 patent/US6447996B1/en not_active Expired - Fee Related
-
2002
- 2002-06-10 US US10/166,568 patent/US20030166895A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK0745122T3 (da) | 2009-03-30 |
JP3989536B2 (ja) | 2007-10-10 |
FR2716205A1 (fr) | 1995-08-18 |
US20030166895A1 (en) | 2003-09-04 |
ES2317643T3 (es) | 2009-04-16 |
FR2716205B1 (fr) | 1996-04-12 |
EP0745122A1 (de) | 1996-12-04 |
EP0745122B1 (de) | 2008-11-19 |
US6447996B1 (en) | 2002-09-10 |
JPH09510344A (ja) | 1997-10-21 |
CA2182621A1 (fr) | 1995-08-24 |
ATE414771T1 (de) | 2008-12-15 |
PT745122E (pt) | 2009-02-10 |
CA2182621C (fr) | 2011-06-14 |
WO1995022608A1 (fr) | 1995-08-24 |
AU1814995A (en) | 1995-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69940431D1 (de) | Brennstoffzellensystem und zellensteuerungsverfahren | |
DE69520426D1 (de) | Zellbindemittel und elektrodenzusammensetzung sowie daraus hergestellte zelle | |
DE69519547D1 (de) | Reformer und diesen verwendendes Brennstoffzellensystem | |
BR9405507A (pt) | Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica | |
DE69842244D1 (de) | Polymerelectrolytbrennstoffzelle und zugehörige bipolare Trennwand | |
TR200000073T2 (tr) | 5-HT6 Reseptör antagonistleri olan sülfonamid türevleri ve bunların hazırlanma prosesi | |
DE60124974D1 (de) | Elektrodenkatalysator und elektrochemische Vorrichtungen unter Verwendung derselben | |
ATE443719T1 (de) | Interleukin-18 bindende proteine, deren herstellung und verwendung | |
DE59813875D1 (de) | Ko-stimulierendes polypeptid von t-zellen, monoklonale antikörper sowie die herstellung und deren verwendung | |
DE97905729T1 (de) | Als 2f1 bezeichnetes rezeptorprotein | |
DE69825911D1 (de) | Knochersatzmaterial | |
ATE358731T1 (de) | Polypeptide mit 4-cumarate:coa ligase-aktivität und deren verwendungen. | |
DE60142072D1 (de) | Positivelektrodenmaterial und dieses enthaltende zelle | |
NO995182L (no) | Pattedyrcytokinlignende faktor 7 | |
DE69535886D1 (de) | Galaninrezeptor, nukleinsäuren,transformierte zellen und verwendungen | |
DE69836950D1 (de) | Verbundmaterial auf basis von hexacyanoferraten und polymer , dessen herstellungsverfahren und verwendung | |
DE69927268D1 (de) | Spezifische antikörper enthaltende bindungsproteine die das nekrotische tumorzentrum binden und deren verwendung | |
DE69819124D1 (de) | Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna | |
DE69837190D1 (de) | Elektroden-Materialien zur Verwendung in Batterien,und Elektroden und Batterien, in denen diese verwendet werden | |
IL90334A0 (en) | Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides | |
IT1291859B1 (it) | Perfezionamento nei dispositivi di tenuta stagna per bottone di comando di strumenti, particolarmente per la corona di carica e di | |
DE69514317D1 (de) | Brennstoffzellenanode und Brennstoffzelle | |
DE69533796D1 (de) | Für die glutamatabhängigen chloridkanäle kodierende dna | |
ATE294861T1 (de) | Polypeptide mit opioider rezeptor-aktvität, für sie kodierende nukleinsäuren und ihre verwendungen | |
FR2732978B1 (fr) | Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |